Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Typhoid Vaccine Articles

Acambis' six month loss down 16% as R&D costs fall; awaits warmbase deal

1 October 2007

Acambis' 1st-qtr sales fall 56.6%

21 May 2007

Acambis sells Berna to Crucell for $16.5M

9 October 2006

Acambis sees flat 1st-qtr sales and losses double

15 May 2006

Upbeat messages from companies presenting at EC21 conference

12 April 2004

Acambis reviews strategic projects

9 February 2004

Acambis opens up US window via BPC deal

8 September 2003

New typhoid vaccine launched in india

19 May 2003

Swiss Berna to buy rival German vaccine maker Rhein Biotech for 279 million euros

3 June 2002

Acambis and Berna in vaccine cross-licensing deal

22 March 2001

Vietnam plan to boost vaccines output

20 January 2000

Peptide Therapeutics sees shares plummet on allergy vaccine failure

7 July 1999

Microscience raises $9m

10 June 1999

Peptide Therapeutics' vaccine progress

11 January 1999

First Launch Of SB's New Typhoid Vaccine

13 August 1998

HMR India Aims To Double Its Vaccine Output

7 August 1998

Typhoid Vaccine In India

16 July 1998

Peptide's Typhoid Vaccine

8 April 1998

Connaught's Typhim Vi Launched In USA

12 December 1994

EVANS LAUNCHES VIVOTIF IN UK

15 June 1992

MEDEVA'S ROAD TO SUCCESS

16 March 1992

Showing 1-21 of 21 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS